A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II

Diabetes Technology and Therapeutics

Volumn 20, Issue 3, 2018, Pages 197-206

  Christiansen, Mark P ^a   Klaff, Leslie J ^b   Brazg, Ronald ^b   Chang, Anna R ^c   Levy, Carol J ^d   Lam, David ^d   Denham, Douglas S ^e   Atiee, George ^f   Bode, Bruce W ^g   Walters, Steven J ^h   Kelley, Lynne ^h   Bailey, Timothy S ⁱ  

^a Diablo Clinical Research   (United States)

^b Rainier Clin Research Clinic Inc   (United States)

^c John Muir Physician Network Clinical Research Center   (United States)

^d Mount Sinai Diabetes Center   (United States)

^e Clinical Trials of Texas Inc   (United States)

^f Worldwide Clinical Trials Drug Development Solutions   (United States)

^g Atlanta Diabetes Association   (United States)

^h Senseonics   (United States)

ⁱ AMCR Institute Inc   (United States)

Author keywords

Accuracy; Continuous glucose monitoring; Implantable; Longevity; Type 1 diabetes; Type 2 diabetes

Indexed keywords

DEXAMETHASONE ACETATE; GLUCOSE; POLY(METHYL METHACRYLATE); ANTIDIABETIC AGENT; INSULIN;

ADULT; ALGORITHM; APPLICATION SITE DISCOMFORT; ARM PAIN; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; CONTROLLED STUDY; DEVICE FAILURE; DEVICE SAFETY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEASUREMENT ERROR; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PAIN; PARESTHESIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SKIN BRUISING; SKIN TINGLING; ANALYSIS; BLOOD; CLINICAL TRIAL; DEVICES; EQUIPMENT DESIGN; EVALUATION STUDY; GLUCOSE BLOOD LEVEL; INSULIN INFUSION; REPRODUCIBILITY;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS;

EID: 85044470223     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2017.0142     Document Type: Article

References (28)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010;33:17-22.
2. Raccah D, Sulmont V, Reznik Y, et al.: Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care 2009;32:2245-2250.
3. O'Connell MA, Donath S, O'Neal DN, et al.: Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009;52:1250-1257.
4. Battelino T, Conget I, Olsen B, et al.: The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia 2012;55:3155-3162.
5. Battelino T, Phillip M, Bratina N, et al.: Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795-800.
6. Frontino G, Bonfanti R, Scaramuzza A, et al.: Sensoraugmented pump therapy in very young children with type 1 diabetes: an efficacy and feasibility observational study. Diabetes Technol Ther 2012;14:762-764.
7. Hommel E, Olsen B, Battelino T, et al.: Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study. Acta Diabetol 2014;51:845-851.
8. Beck RW, Riddlesworth TD, Ruedy K, et al.: Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med 2017;167:365-374.
9. Bergenstal RM, Tamborlane WV, Ahmann A, et al.: Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care 2011;34:2403-2405.
10. Garg SK, Voelmle MK, Beatson CR, et al.: Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study. Diabetes Care 2011;34:574-579.
11. Wong JC, Foster NC, Maahs DM, et al.: Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care 2014;37:2702-2709.
12. Mortellaro M, DeHennis A: Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes. Biosens Bioelectron 2014;61:227-231.
13. DeHennis A, Mailand M, Grice D, et al.: A near-fieldcommunication (NFC) enabled wireless fluorimeter for fully implantable biosensing applications. 2013 IEEE International Solid-State Circuits Conference Digest of Technical Papers (ISSCC), San Francisco, CA, February 17-21, 2013, pp. 298-299.
14. Wang X, Mdingi C, DeHennis A, Colvin AE: Algorithm for an implantable fluorescence based glucose sensor. Conf Proc IEEE Eng Med Biol Soc 2012;2012:3492-3495.
15. Wang X, Ioacara S, DeHennis A: Long-term home study on nocturnal hypoglycemic alarms using a new fully implantable continuous glucose monitoring system in type 1 diabetes. Diabetes Technol Ther 2015;17:780-786.
16. Bequette BW: Challenges and recent progress in the development of a closed-loop artificial pancreas. Annu Rev Control 2012;36:255-266.
17. Baysal N, Cameron F, Buckingham BA, et al.: A novel method to detect pressure-induced sensor attenuations (PISA) in an artificial pancreas. J Diabetes Sci Technol 2014;8:1091-1096.
18. Kropff J, Choudhary P, Neupane S, et al.: Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE Study: a 180-day, prospective, multicenter, pivotal trial. Diabetes Care 2017;40:63-68.
19. Facchinetti A: Continuous glucose monitoring sensors: past, present and future algorithmic challenges. Sensors (Basel) 2016;16:2093.
20. Colvin AE, Jiang H: Increased in vivo stability and functional lifetime of an implantable glucose sensor through platinum catalysis. J Biomed Mater Res 2013; 101A:1274-1282.
21. Clarke WL: The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther 2005;7:776-779.
22. Kropff J, Bruttomesso D, Doll W, et al.: Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions. Diabetes Obes Metab 2015;17:343-349.
23. Bailey TS, Chang A, Christiansen M: Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol 2015;9:209-214.
24. Thabit H, Leelarathna L, Wilinska ME, et al.: Accuracy of continuous glucose monitoring during three closed-loop home studies under free-living conditions. Diabetes Technol Ther 2015;17:801-807.
25. Luijf YM, Mader JK, Doll W, et al.: Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. Diabetes Technol Ther 2013; 15:721-726.
26. Heinemann L, Kamann S: Adhesives used for diabetes medical devices: a neglected risk with serious consequences? J Diabetes Sci Technol 2016;10:1211-1215.
27. Schwensen JF, Friis UF, Zachariae C, Johansen JD: Sensitization to cyanoacrylates caused by prolonged exposure to a glucose sensor set in a diabetic child. Contact Dermatitis 2016;74:124-125.
28. Barnard KD, Kropff J, Choudhary P, et al.: Acceptability of implantable continuous glucose monitoring sensor. J Diabetes Sci Technol 2017; doi:10.1177/1932296817735123. Accessed January 26, 2018.